Developed a proprietary biomarker discovery platform (MVA) to identify antibody signatures for a variety of diseases. MVA makes this possible through a unique combination of phage display screening, next-generation sequencing, and big data analytics. IPDx applies MVA to develop diagnostics for a variety of diseases and collaborates with researchers interested in biomarker discovery, vaccine development, and multiplex diagnostic panel development.
Get a demo today to see profiles of Spineology plus 6164 other startups.
Trusted By The Companies Pioneering What’s Next
Join the LSI Mailing List
Upcoming Events
17011 Beach Blvd, Suite 500
Huntington Beach, CA 92647
© 2026 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy | Your Privacy Choices | Delete my Data